Colgate-Palmolive
2,007 hedge funds and large institutions have $61.2B invested in Colgate-Palmolive in 2026 Q2 according to their latest regulatory filings, with 191 funds opening new positions, 725 increasing their positions, 722 reducing their positions, and 101 closing their positions.
89% more first-time investments, than exits
New positions opened: 191 | Existing positions closed: 101
35% more call options, than puts
Call options by funds: $425M | Put options by funds: $314M
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
2% more funds holding
Funds holding: 1,959 → 2,007 (+48)
3% more capital invested
Capital invested by funds: $59.6B → $61.2B (+$1.63B)
0% more repeat investments, than reductions
Existing positions increased: 725 | Existing positions reduced: 722
0.54% less ownership
Funds ownership: 84.02% → 83.48% (-0.54%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$253M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$122M |
| 3 |
Morgan Stanley
New York
|
+$104M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$101M |
| 5 |
Amundi
Paris,
France
|
+$90.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$509M |
| 2 |
BlackRock
New York
|
-$239M |
| 3 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
-$204M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$155M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$153M |
CL Hedge Fund Activity: Q2 2026 in Review
2,007 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q2 2026, worth a combined $61.2B — up 2.7% from $59.6B a quarter earlier.
Buyers outnumbered sellers: 191 funds opened new CL positions and 101 closed out — a net gain of 90 holders — while 725 added to existing stakes and 722 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $253M. The largest seller was T. Rowe Price Associates, cutting an estimated $509M.
- 2,007 institutional investors held Colgate-Palmolive (CL) as of Q2 2026, up from 1,959 in Q1 2026.
- Funds reported $61.2B of Colgate-Palmolive stock for Q2 2026, up 2.7% quarter-over-quarter.
- 191 funds opened new Colgate-Palmolive positions in Q2 2026 and 101 closed out, a net change of +90 holders.
- The largest Colgate-Palmolive buyer in Q2 2026 was AQR Capital Management, an estimated $253M added.
- The largest Colgate-Palmolive seller in Q2 2026 was T. Rowe Price Associates, an estimated $509M sold.
Based on aggregated 13F filings for Q2 2026.